8247 Stock Overview
Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagent products in Mainland China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Biosino Bio-Technology and Science Incorporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.70 |
| 52 Week High | HK$1.24 |
| 52 Week Low | HK$0.48 |
| Beta | -0.080 |
| 1 Month Change | 25.00% |
| 3 Month Change | -18.60% |
| 1 Year Change | -40.68% |
| 3 Year Change | -53.33% |
| 5 Year Change | -54.25% |
| Change since IPO | -74.31% |
Recent News & Updates
Is Biosino Bio-Technology and Science Incorporation (HKG:8247) Using Debt In A Risky Way?
Apr 01
Biosino Bio-Technology and Science Incorporation's (HKG:8247) 31% Dip In Price Shows Sentiment Is Matching Revenues
Feb 08Recent updates
Is Biosino Bio-Technology and Science Incorporation (HKG:8247) Using Debt In A Risky Way?
Apr 01Biosino Bio-Technology and Science Incorporation's (HKG:8247) 31% Dip In Price Shows Sentiment Is Matching Revenues
Feb 08Some Confidence Is Lacking In Biosino Bio-Technology and Science Incorporation (HKG:8247) As Shares Slide 38%
Jul 31We Think That There Are Issues Underlying Biosino Bio-Technology and Science Incorporation's (HKG:8247) Earnings
Aug 19Shareholder Returns
| 8247 | HK Biotechs | HK Market | |
|---|---|---|---|
| 7D | 0% | -8.2% | -0.7% |
| 1Y | -40.7% | -46.6% | -13.4% |
Return vs Industry: 8247 exceeded the Hong Kong Biotechs industry which returned -46.6% over the past year.
Return vs Market: 8247 underperformed the Hong Kong Market which returned -13.4% over the past year.
Price Volatility
| 8247 volatility | |
|---|---|
| 8247 Average Weekly Movement | 16.4% |
| Biotechs Industry Average Movement | 9.5% |
| Market Average Movement | 7.5% |
| 10% most volatile stocks in HK Market | 14.9% |
| 10% least volatile stocks in HK Market | 3.8% |
Stable Share Price: 8247's share price has been volatile over the past 3 months.
Volatility Over Time: 8247's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 537 | Peng Chen | www.sinobio.com.cn |
Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagent products in Mainland China. It offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; time-resolved fluoroimmunoassay analyzers; and flow cytometers and bio chemical analyzers. The company also provides medical and medical inspection services; produces medical instruments; and distributes biological reagents and instruments.
Biosino Bio-Technology and Science Incorporation Fundamentals Summary
| 8247 fundamental statistics | |
|---|---|
| Market cap | HK$101.30m |
| Earnings (TTM) | -HK$12.60m |
| Revenue (TTM) | HK$312.76m |
0.3x
P/S Ratio-8.0x
P/E RatioIs 8247 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8247 income statement (TTM) | |
|---|---|
| Revenue | CN¥289.07m |
| Cost of Revenue | CN¥161.71m |
| Gross Profit | CN¥127.37m |
| Other Expenses | CN¥139.01m |
| Earnings | -CN¥11.65m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.08 |
| Gross Margin | 44.06% |
| Net Profit Margin | -4.03% |
| Debt/Equity Ratio | 61.7% |
How did 8247 perform over the long term?
See historical performance and comparison